Our studies provide evidence of the concept of covalently linking an appropriate anti-tumor agent to the carboxyl group of ubenimex to maintain potent CD13 inhibitory activity and significantly enhance the anti-cancer efficacy in vitro and in vivo. Here, ANPEP is linked to neoplasm.